BiotechTube
Home/Corteria Pharmaceuticals/Marie-Laure Ozoux
MO

Marie-Laure Ozoux

CSO

Corteria Pharmaceuticals

Therapeutic Areas

CardiovascularMetabolic DisordersMusculoskeletal

Corteria Pharmaceuticals Pipeline

DrugIndicationPhase
COR-1167Worsening Heart FailurePhase 2
COR-1389Obesity and Right Heart FailurePhase 1
Vasopressin Neutralizing AntibodyHeart Failure (implied)Preclinical

Leadership Team at Corteria Pharmaceuticals

PJ
Philip Janiak
CEO
RO
Régis Olivier
CAO
FC
Francesca C. Lawson
CMO
View full Corteria Pharmaceuticals profile